|
Volumn 27, Issue 12, 2008, Pages 1099-1101
|
Caspofungin for the treatment of pediatric fungal infections
a,b a,b |
Author keywords
candidiasis; Echinocandins; pediatrics; treatment
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
CARBAMAZEPINE;
CASPOFUNGIN;
CYCLOSPORIN;
DEXAMETHASONE;
EFAVIRENZ;
NEVIRAPINE;
PHENYTOIN;
PYRROLE DERIVATIVE;
RIFAMPICIN;
ANTIFUNGAL AGENT;
ECHINOCANDIN;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIFUNGAL ACTIVITY;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
ASPERGILLOSIS;
ASPERGILLUS;
CANDIDA;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG DEGRADATION;
DRUG DISTRIBUTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG WITHDRAWAL;
ESOPHAGUS CANDIDIASIS;
FEVER;
HUMAN;
INVASIVE CANDIDIASIS;
MYCOSIS;
NONHUMAN;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RASH;
SHORT SURVEY;
SIDE EFFECT;
UNSPECIFIED SIDE EFFECT;
CANDIDIASIS;
CHILD;
DRUG EFFECT;
FOOD AND DRUG ADMINISTRATION;
INFANT;
PRESCHOOL CHILD;
REVIEW;
UNITED STATES;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
ASPERGILLUS;
CANDIDA;
CANDIDIASIS;
CHILD;
CHILD, PRESCHOOL;
DRUG APPROVAL;
ECHINOCANDINS;
HUMANS;
INFANT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 58149395905
PISSN: 08913668
EISSN: 15320987
Source Type: Journal
DOI: 10.1097/INF.0b013e3181937fe0 Document Type: Article |
Times cited : (14)
|
References (15)
|